Titre :
  • Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2 [ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumors.
Auteur : Stahel, R A ; Sculier, Jean-Paul ; Jost, L M ; Delforge, Alain ; Bron, Dominique ; Gmür, J ; Oelz, O ; Sauter, C ; Stryckmans, Pierre ; Klastersky, Jean
Informations sur la publication : European journal of cancer & clinical oncology, 25, 6, (page 965-972)
Statut de publication : Publié, 1989-06
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Aged
Carcinoma, Renal Cell -- secondary
Carcinoma, Renal Cell -- therapy
Drug Evaluation
Drug Tolerance
Female
Humans
Interleukin-2 -- adverse effects
Interleukin-2 -- therapeutic use
Kidney Neoplasms
Killer Cells, Natural
Leukapheresis
Lymphocyte Activation
Male
Middle Aged
Neoplasms -- therapy
Recombinant Proteins -- adverse effects
Recombinant Proteins -- therapeutic use
Note : Journal Article
SCOPUS: ar.j
Langue :
  • Anglais
Identificateurs : urn:issn:0277-5379 
info:doi/10.1016/0277-5379(89)90155-7
info:pii/0277537989901557
info:pmid/2787749